You are here: vision-research.eu » People » Research Groups » United Kingdom » Coupland, Sarah

Liverpool Ocular Oncology Research Group (LOORG)

The Liverpool Ocular Oncology Research Group’s (LOORG’s) mission is to conduct high quality basic, translational and clinical research into the pathogenesis and treatment of adult ocular tumours that will improve patient care and survival. The Liverpool Ocular Oncology Research Group (LOORG) was established by Professor Sarah Coupland and Professor Bertil Damato in 2006. Prof. Coupland has since lead the basic science and translational research portfolio, in addition to being a Consultant Pathologist at the Royal Liverpool University Hospital.

A major strength of the LOORG is the close collaboration between ocular oncology clinicians (Lead, Professor Heimann), pathologists and basic scientists (Dr Sarah Lake and Dr Helen Kalirai) which ensures that the research we conduct addresses the key questions that will bring about improved survival and quality of life for ocular oncology patients.

Group Leader

Sarah E. Coupland
[more information]

Contact

University of Liverpool

Molecular and Clinical Cancer Medicine
Institute of Translational Medicine
6th Floor, Duncan Building
L69 3GA Liverpool
United Kingdom

Phone: +44(0)151 706 4494
Fax: +44(0)151 706 5826

E-mail:
s.e.coupland[at]liverpool.ac.uk

Website:
www.loorg.org

Current Research Projects

  • Project 1:
    Identification of regulators of metastasis in uveal melanoma
  • Project 2:
    Proteomic discovery of serum biomarkers in metastatic uveal melanoma
  • Project 3:
    Estimating survival prognosis after treatment of choroidal melanoma
  • Project 4:
    Gross chromosomal abnormalities in iris melanoma
  • Project 5:
    Molecular characteristics of metastatic liver lesions in uveal melanoma: the search for therapeutic targets

Research Groups

People

Related Research Groups

clinical laboratory testing
Oops, an error occurred! Code: 20190616013603b71624bc
conjunctiva
Oops, an error occurred! Code: 201906160136037337879f
disease gene mapping
Oops, an error occurred! Code: 201906160136033e0f8dbc
gene/expression
Oops, an error occurred! Code: 20190616013603b49827c1
gene microarray
Oops, an error occurred! Code: 20190616013603bf580a42
genetics
Oops, an error occurred! Code: 2019061601360365bd281a
immunohistochemistry
Oops, an error occurred! Code: 201906160136037bfea325
iris
Oops, an error occurred! Code: 201906160136038899a186
melanoma
Oops, an error occurred! Code: 20190616013603bd67dccb
oncology
Oops, an error occurred! Code: 2019061601360338b455a0
pathology: experimental
Oops, an error occurred! Code: 201906160136033d0951a6
pathology: human
Oops, an error occurred! Code: 201906160136038f0e5d27
pathology techniques
Oops, an error occurred! Code: 201906160136032be04281
tumors
Oops, an error occurred! Code: 20190616013603fc73fdc1
uvea
Oops, an error occurred! Code: 20190616013603b182f0a2
vision and action
Oops, an error occurred! Code: 20190616013603e464794a
visual acuity
Oops, an error occurred! Code: 20190616013603de265c8e
uveal melanoma
Oops, an error occurred! Code: 2019061601360342629dc3
conjunctival melanoma
Oops, an error occurred! Code: 20190616013603f8c79f7f
intraocular and ocular adnexal lymphomas
Oops, an error occurred! Code: 20190616013603ade60b10
pathology
Oops, an error occurred! Code: 20190616013603cbcecd0c
translational studies
Oops, an error occurred! Code: 20190616013603be41f532